SCHEMBL16135409

SCHEMBL16135409

Cc1cc(Cl)cc(-c2nc(C3CC3)[nH]c2-c2ccnc(N)n2)c1F

nearest known ligand 0.74

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
BRAF P15056 19/20 0.74
MAPK13 O15264 1/20 0.48
MAPK9 P45984 1/20 0.48
MAPK12 P53778 1/20 0.48
MAPK11 Q15759 1/20 0.48
MAPK14 Q16539 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6521494 0.85 BRAF (1.00) BRAF
SCHEMBL1494592 0.79 BRAF (1.00) BRAF
SCHEMBL13977474 0.75 JAK2 (0.72) BRAFMAPK13MAPK9MAPK12
SCHEMBL1494655 0.75 BRAF (1.00) BRAF
SCHEMBL12830512 0.73 BRAF (0.82) BRAF
SCHEMBL1494598 0.72 BRAF (0.76) BRAF
SCHEMBL6521524 0.71 BRAF (1.00) BRAF
SCHEMBL4585531 0.71 MAPK14 (0.57) BRAFMAPK13MAPK9MAPK12MAPK11
SCHEMBL4187423 0.70 JAK2 (0.76) MAPK13MAPK9MAPK12
SCHEMBL1494679 0.70 BRAF (0.80) BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2470528-B1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS NOVARTIS AG (CH) 2014-10-01 EP disclosed